§516.29. Termination of MUMS-drug designation. — Inbound Citations

21 C.F.R. § 516.29

Statutory Authority

Cited by 2 regulations in release Current.

21 C.F.R. § 516.31(a)(1)

Go to provision →

(1) FDA terminates the MUMS-drug designation and associated exclusive marketing rights under § 516.29; or
21 C.F.R. § 516.52(d)

Go to provision →

(d) In accordance with § 516.28, FDA will make a cumulative list of all MUMS-drug designations available to the public and update such list periodically. In accordance with § 516.29, FDA will give public notice of the termination of all MUMS-drug designations.